The FDA announced on December 23, 2013, that Hospira Inc. voluntarily recalled Lidocaine HCl Injection due to the presence of particulate matter. The recall affects 68,350 vials distributed nationwide.
How to tell if you have it
- Brand: Hospira
- Product: Lidocaine HCl Injection, USP, 2%, 20 mg per mL
- Packaging: 5-mL single-dose vials, 10 vials per box
- NDC: 0409-2066-05
- Lot Code: 32135DD
- Expiration Date: 08/15
- Quantity: 68,350 vials
The hazard
The recall was initiated following a confirmed customer complaint of particulates embedded in the glass container and in contact with the product solution. The FDA classified this as a Class I recall.
Context
GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls of similar products include Asclemed Lidocaine HCl Injection Recall (June 8, 2026), American Regent Papaverine HCl Injection Recall (July 24, 2026), and Fresenius Kabi Lidocaine HCl Injection Recall (July 16, 2026).